Your browser doesn't support javascript.
loading
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.
Demaria, Olivier; Gauthier, Laurent; Vetizou, Marie; Blanchard Alvarez, Audrey; Vagne, Constance; Habif, Guillaume; Batista, Luciana; Baron, William; Belaïd, Nourhène; Girard-Madoux, Mathilde; Cesari, Cedric; Caratini, Melody; Bosco, Frédéric; Benac, Olivier; Lopez, Julie; Fenis, Aurore; Galluso, Justine; Trichard, Sylvia; Carrette, Barbara; Carrette, Florent; Maguer, Aurélie; Jaubert, Solène; Sansaloni, Audrey; Letay-Drouet, Robin; Kosthowa, Camille; Lovera, Naouel; Dujardin, Arnaud; Chanuc, Fabien; Le Van, Mélanie; Bokobza, Sivan; Jarmuzynski, Nicolas; Fos, Camille; Gourdin, Nicolas; Remark, Romain; Lechevallier, Eric; Fakhry, Nicolas; Salas, Sébastien; Deville, Jean-Laurent; Le Grand, Roger; Bonnafous, Cécile; Vollmy, Lukas; Represa, Agnès; Carpentier, Sabrina; Rossi, Benjamin; Morel, Ariane; Cornen, Stéphanie; Perrot, Ivan; Morel, Yannis; Vivier, Eric.
Afiliação
  • Demaria O; Innate Pharma, Marseille, France. Electronic address: olivier.demaria@innate-pharma.fr.
  • Gauthier L; Innate Pharma, Marseille, France.
  • Vetizou M; Innate Pharma, Marseille, France.
  • Blanchard Alvarez A; Innate Pharma, Marseille, France.
  • Vagne C; Innate Pharma, Marseille, France.
  • Habif G; Innate Pharma, Marseille, France.
  • Batista L; Innate Pharma, Marseille, France.
  • Baron W; Innate Pharma, Marseille, France.
  • Belaïd N; Innate Pharma, Marseille, France.
  • Girard-Madoux M; Innate Pharma, Marseille, France.
  • Cesari C; Innate Pharma, Marseille, France.
  • Caratini M; Innate Pharma, Marseille, France.
  • Bosco F; Innate Pharma, Marseille, France.
  • Benac O; Innate Pharma, Marseille, France.
  • Lopez J; Innate Pharma, Marseille, France.
  • Fenis A; Innate Pharma, Marseille, France.
  • Galluso J; Innate Pharma, Marseille, France.
  • Trichard S; Innate Pharma, Marseille, France.
  • Carrette B; Innate Pharma, Marseille, France.
  • Carrette F; Innate Pharma, Marseille, France.
  • Maguer A; Innate Pharma, Marseille, France.
  • Jaubert S; Innate Pharma, Marseille, France.
  • Sansaloni A; Innate Pharma, Marseille, France.
  • Letay-Drouet R; Innate Pharma, Marseille, France.
  • Kosthowa C; Innate Pharma, Marseille, France.
  • Lovera N; Innate Pharma, Marseille, France.
  • Dujardin A; Innate Pharma, Marseille, France.
  • Chanuc F; Innate Pharma, Marseille, France.
  • Le Van M; Innate Pharma, Marseille, France.
  • Bokobza S; Innate Pharma, Marseille, France.
  • Jarmuzynski N; Innate Pharma, Marseille, France.
  • Fos C; Innate Pharma, Marseille, France.
  • Gourdin N; Innate Pharma, Marseille, France.
  • Remark R; Innate Pharma, Marseille, France.
  • Lechevallier E; Assistance Publique des Hôpitaux de Marseille, Chirurgie Urologique et Transplantation Rénale, Hôpital de la Conception, Marseille, France.
  • Fakhry N; Assistance Publique des Hôpitaux de Marseille, ORL et Chirurgie Cervico-Faciale, Hôpital de la Conception, Marseille, France.
  • Salas S; Assistance Publique des Hôpitaux de Marseille, Service d'Oncologie Médicale et de Soins Palliatifs, CHU Timone Adulte, Marseille, France.
  • Deville JL; Assistance Publique des Hôpitaux de Marseille, Oncologie Médicale, Hôpital de la Timone, Marseille, France.
  • Le Grand R; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Bonnafous C; Innate Pharma, Marseille, France.
  • Vollmy L; Innate Pharma, Marseille, France.
  • Represa A; Innate Pharma, Marseille, France.
  • Carpentier S; Innate Pharma, Marseille, France.
  • Rossi B; Innate Pharma, Marseille, France.
  • Morel A; Innate Pharma, Marseille, France.
  • Cornen S; Innate Pharma, Marseille, France.
  • Perrot I; Innate Pharma, Marseille, France.
  • Morel Y; Innate Pharma, Marseille, France.
  • Vivier E; Innate Pharma, Marseille, France; Aix Marseille University, CNRS, INSERM, CIML, Marseille, France; Assistance Publique des Hôpitaux de Marseille, Hôpital de la Timone, Marseille-Immunopôle, Marseille, France. Electronic address: vivier@ciml.univ-mrs.fr.
Cell Rep Med ; 3(10): 100783, 2022 10 18.
Article em En | MEDLINE | ID: mdl-36260981
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-2 / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-2 / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article